Latest filing published 03 Jan 2019 for Oncternal Therapeutics, Inc., €14k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Joseph R. Hyde III: trading record in brief
Joseph R. Hyde III discloses dealings in 3 companies, chiefly Oncternal Therapeutics, Inc., Autozone Inc and FedEx Corp. Between 1 January 2006 and 2 January 2019, the trades on record add up to 196 filings.
On the open market, the record shows 28 purchases worth €17.9M and 2 sales worth €9,426. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 106 share grants and 20 option exercises.
Half of the purchases are above €152k and half below.
Most recently, on 3 January 2019, the filings show a share grant worth €14k in Oncternal Therapeutics, Inc. The latest purchase dates back some time: it was published 4,626 days ago, on 10 March 2014. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joseph R. Hyde III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,168.605 shares@ US$0.8620.6% of flowCommon StockSEC:0001179110-19-000216:0
- 10,416.67 shares@ US$1.5017.0% of flowCommon StockSEC:0001179110-18-011926:0
- 1,010.02 shares@ US$15.4714.4% of flowCommon StockSEC:0001179110-18-009273:0
- 894.39 shares@ US$17.470.2% of flowCommon StockSEC:0001179110-18-005242:0
- 1,363.44 shares@ US$11.460.2% of flowCommon StockSEC:0001179110-18-000481:0
- 302.23 shares@ US$711.3718.0% of flowCommon StockSEC:0001225208-18-000084:0
- 3,000 shares@ US$119.1530.5% of flowCommon StockSEC:0001225208-17-018670:0
- 1,967.88 shares@ US$7.940.2% of flowCommon StockSEC:0001179110-17-013086:0
- 1,130,582 sharesCommon StockSEC:0001179110-17-012838:0
- 2,970.53 shares@ US$5.260.2% of flowCommon StockSEC:0001179110-17-010009:0
- 3,188.78 shares@ US$4.900.3% of flowCommon StockSEC:0001179110-17-005782:0
- 2,999.04 shares@ US$5.210.3% of flowCommon StockSEC:0001179110-17-000264:0
- 259.56 shares@ US$789.7919.4% of flowCommon StockSEC:0001225208-17-000099:0
- 3,000 shares@ US$116.3532.1% of flowCommon StockSEC:0001225208-16-040794:0
- 7,716,049 shares@ US$0.8197.9% of flowCommon StockSEC:0001179110-16-030749:0
- 20,559.21 shares0Common StockSEC:0001179110-16-030309:0
- 31,410 shares0Common StockSEC:0001225208-16-037266:0
- 28,409.09 shares0Common StockSEC:0001179110-16-027354:0
- 27,901.79 shares0Common StockSEC:0001179110-16-022673:0
- 22,007.04 sharesCommon StockSEC:0001179110-16-017084:0
- 276.31 sharesCommon StockSEC:0001225208-16-023194:0
- 3,000 shares@ US$92.22Common StockSEC:0001225208-15-022058:0
- 19,500 shares0Common StockSEC:0001179110-15-013616:0
- 9,685.43 shares0Common StockSEC:0001179110-15-010698:0
- 85,000 shares0Common StockSEC:0001225208-15-013528:0
25 of 159 declarations